Golimumab

Details

Files
Generic Name:
Golimumab
Project Status:
Complete
Therapeutic Area:
Arthritis, psoriatic
Manufacturer:
Centocor Inc.
Brand Name:
Simponi
Project Line:
Reimbursement Review
Project Number:
SR0195-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Arthritis, psoriatic
Recommendation Type:
List in a similar manner
Final Recommendation: